VAS.DEVAS.DEXETRA
Loading
EBITDA Over TimeContracting
Percentile Rank7
3Y CAGR-31.6%
5Y CAGR-6.2%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-31.6%/yr
vs +11.4%/yr prior
5Y CAGR
-6.2%/yr
Recent deceleration
Acceleration
-43.0pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$778.80M-44.3%
2025$1.40B-19.5%
2024$1.74B-28.7%
2023$2.44B+10.6%
2022$2.20B+105.3%
2021$1.07B+35.0%
2020$795.30M-49.8%
2019$1.58B-18.9%
2018$1.95B+24.6%
2017$1.57B-